IDO-IN-5 (NLG-1489) (Synonyms: NLG-1489) |
Katalog-Nr.GC34137 |
IDO-IN-5 (NLG-1489) (NLG-1489) ist ein Indolamin-2,3-Dioxygenase (IDO)-Inhibitor, extrahiert aus dem Patent WO WO2012142237A1, Verbindung 1489, hat einen IC50 von 1-10 μM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1402837-79-9
Sample solution is provided at 25 µL, 10mM.
IDO-IN-5 (NLG-1489) is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO WO2012142237A1, compound 1489, has an IC50 of 1-10 μM.
IDO-IN-5 (Compound 1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC50 of 1-10 μM (this is the concentration of IDO-IN-5 at which inhibits 50% of enzymatic activity using recombinant human IDO)[1].
[1]. Mario Mautino, et al. Fused imidazole derivatives useful as ido inhibitors. WO 2012142237 A1.
Average Rating: 5
(Based on Reviews and 23 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *